Barinthus Biotherapeutics (BRNS) Shareholder's Equity (2020 - 2026)
Barinthus Biotherapeutics (BRNS) Shareholder's Equity (2020 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 502.95 Mn |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | 66.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.40 Mn |
| Dec 31, 2025 | 74.21 Mn |
| Sep 30, 2025 | 84.56 Mn |
| Jun 30, 2025 | 102.48 Mn |
| Mar 31, 2025 | 115.59 Mn |
| Dec 31, 2024 | 130.14 Mn |
| Sep 30, 2024 | 159.46 Mn |
| Jun 30, 2024 | 156.79 Mn |
| Mar 31, 2024 | 172.02 Mn |
| Dec 31, 2023 | 187.00 Mn |
| Sep 30, 2023 | 195.60 Mn |
| Jun 30, 2023 | 217.46 Mn |
| Mar 31, 2023 | 233.57 Mn |
| Dec 31, 2022 | 243.20 Mn |
| Sep 30, 2022 | 244.15 Mn |
| Jun 30, 2022 | 254.77 Mn |
| Mar 31, 2022 | 253.14 Mn |
| Dec 31, 2021 | 252.56 Mn |
| Sep 30, 2021 | 242.47 Mn |
| Jun 30, 2021 | 249.91 Mn |